Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naila Goldenberg

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
The Journal of Laboratory and Clinical Medicine|March 10, 2004
Nonarteritic anterior ischemic optic neuropathy: associations with homozygosity for the C677T methylenetetrahydrofolate reductase mutationCharles J Glueck, Ping Wang, Howard Bell, et al.
Metabolism: Clinical and Experimental|November 25, 2004
Metformin-diet benefits in women with polycystic ovary syndrome in the bottom and top quintiles for insulin resistanceNaila Goldenberg, Charles J Glueck, Matt Loftspring, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|December 23, 2008
Enoxaparin-metformin and enoxaparin alone may safely reduce pregnancy lossGanga Ramidi, Naseer Khan, Charles J Glueck, et al.
The Journal of Laboratory and Clinical Medicine|July 25, 2003
Idiopathic intracranial hypertension: associations with coagulation disorders and polycystic-ovary syndromeCharles J Glueck, Srinivas Iyengar, Naila Goldenberg, et al.
Metabolism: Clinical and Experimental|July 19, 2003
Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndromeC J Glueck, Ranganath Papanna, Ping Wang, et al.
The Journal of Clinical Endocrinology and Metabolism|May 22, 2008
Treatment of pituitary gigantism with the growth hormone receptor antagonist pegvisomantNaila Goldenberg, Michael S Racine, Pamela Thomas, et al.
Current Medical Research and Opinion|December 5, 2012
Effects of metformin-diet intervention before and throughout pregnancy on obstetric and neonatal outcomes in patients with polycystic ovary syndromeCharles J Glueck, Naila Goldenberg, Joel Pranikoff, et al.
The Journal of Laboratory and Clinical Medicine|March 5, 2005
Idiopathic intracranial hypertension, polycystic-ovary syndrome, and thrombophiliaCharles J Glueck, Dawit Aregawi, Naila Goldenberg, et al.
Lipids in Health and Disease|July 26, 2017
Efficacy and safety of proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors, alirocumab and evolocumab, a post-commercialization studyJoshua Choi, Amir M Khan, Michael Jarmin, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|December 6, 2006
Changes in weight, papilledema, headache, visual field, and life status in response to diet and metformin in women with idiopathic intracranial hypertension with and without concurrent polycystic ovary syndrome or hyperinsulinemiaCharles J Glueck, Karl C Golnik, Dawit Aregawi, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
The Journal of Laboratory and Clinical Medicine|March 10, 2004
Nonarteritic anterior ischemic optic neuropathy: associations with homozygosity for the C677T methylenetetrahydrofolate reductase mutationCharles J Glueck, Ping Wang, Howard Bell, et al.
Metabolism: Clinical and Experimental|November 25, 2004
Metformin-diet benefits in women with polycystic ovary syndrome in the bottom and top quintiles for insulin resistanceNaila Goldenberg, Charles J Glueck, Matt Loftspring, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|December 23, 2008
Enoxaparin-metformin and enoxaparin alone may safely reduce pregnancy lossGanga Ramidi, Naseer Khan, Charles J Glueck, et al.
The Journal of Laboratory and Clinical Medicine|July 25, 2003
Idiopathic intracranial hypertension: associations with coagulation disorders and polycystic-ovary syndromeCharles J Glueck, Srinivas Iyengar, Naila Goldenberg, et al.
Metabolism: Clinical and Experimental|July 19, 2003
Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndromeC J Glueck, Ranganath Papanna, Ping Wang, et al.
The Journal of Clinical Endocrinology and Metabolism|May 22, 2008
Treatment of pituitary gigantism with the growth hormone receptor antagonist pegvisomantNaila Goldenberg, Michael S Racine, Pamela Thomas, et al.
Current Medical Research and Opinion|December 5, 2012
Effects of metformin-diet intervention before and throughout pregnancy on obstetric and neonatal outcomes in patients with polycystic ovary syndromeCharles J Glueck, Naila Goldenberg, Joel Pranikoff, et al.
The Journal of Laboratory and Clinical Medicine|March 5, 2005
Idiopathic intracranial hypertension, polycystic-ovary syndrome, and thrombophiliaCharles J Glueck, Dawit Aregawi, Naila Goldenberg, et al.
Lipids in Health and Disease|July 26, 2017
Efficacy and safety of proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors, alirocumab and evolocumab, a post-commercialization studyJoshua Choi, Amir M Khan, Michael Jarmin, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|December 6, 2006
Changes in weight, papilledema, headache, visual field, and life status in response to diet and metformin in women with idiopathic intracranial hypertension with and without concurrent polycystic ovary syndrome or hyperinsulinemiaCharles J Glueck, Karl C Golnik, Dawit Aregawi, et al.
Pageof 5